Browse by Day Archive

Ionis Pharma prices first FDA-approved treatment for Alexander disease at $285,000 per dose

09/03/2026 2:28pm
Ionis Pharmaceuticals said on Friday it ​would price its newly approved therapy to treat Alexander disease at $285,000 per dose, a day after the U.S. FDA cleared ‌the injectable drug, making it the first approved treatment for the genetic disorder in ⁠adults and children.

Cyclosporiasis cases in Michigan climb to over 14,700, state health officials say

09/03/2026 12:32pm
Michigan health officials reported 14,718 cases linked to an outbreak of ​cyclosporiasis on Thursday, an increase of 208 cases since its last update a week earlier.

AbbVie's blood cancer therapy lowers disease progression, death risk in trial

09/03/2026 7:21am
AbbVie said on Thursday its therapy for a type of blood ​cancer has improved patients' response rate to treatment and reduced the risk of disease progression or death, meeting the main goals of ‌a late-stage trial.

Aspen sees Mounjaro Africa sales above $124 million in 2027

09/03/2026 6:38am
Aspen Pharmacare expects African sales of Eli Lilly's blockbuster weight-loss ​and diabetes drug Mounjaro to exceed 2 billion rand ($124 million) in its current financial year, buoyed by surging demand in South Africa and ‌planned launches in Nigeria and Kenya.

Health officials turn to mobile-phone data to track Ebola spread in Congo

09/03/2026 5:24am
Health officials battling the Ebola outbreak in eastern Democratic Republic of Congo are using anonymised mobile-phone data to map population movements and identify areas where the virus could spread next, according to the World ​Health Organisation and researchers working with it.

Ultragenyx shares crater after Angelman syndrome drug fails late-stage trial

09/03/2026 4:31am
Shares of Ultragenyx Pharmaceutical plunged on Thursday after its neurodevelopmental ​disorder treatment failed a closely watched late-stage trial, dealing a major blow to one of its biggest growth bets.

Transgene jumps 20% on positive cancer vaccine data in early trial

09/03/2026 2:22am
Transgene shares surged 20% in early Paris ​trading on Thursday, after the French biotechnology company reported positive Phase 1 trial data ‌on its vaccine candidate for head and neck cancer.